CardioProtect’s 2026 Failure: $350M R&D Loss
CardioProtect's drug trial failed, costing PharmaCorp $350M. Learn why this matters for future heart disease treatments and drug development.
CardioProtect's drug trial failed, costing PharmaCorp $350M. Learn why this matters for future heart disease treatments and drug development.
Tech stocks drove 12% S&P 500 growth in 2026. See what's behind the surge beyond AI giants and potential risks for investors.
CoreWeave's $7.5B debt and Supermicro's surge show AI's infrastructure boom. Will gains last amid competition? Get key insights.
Who will win 2027 Insurance Luminaries? Nominations are open until Nov 30, 2026. See key dates, new InsurTech Pioneer award, and what's next.
Prioritize Nike's September 2026 releases: Alphafly 3.0 for runners, a rare Dunk Low SB collab, or the Air Jordan 4 Military Blue retro. What to buy?
Why did a 30% loss hit US investors in emerging markets? Learn what caused the volatility and how to avoid similar risks in global finance.
Employee disengagement costs businesses profit. Learn how to mitigate this workplace risk, reduce turnover by 15%, and boost profitability.
P&C M&A rose 15% in North America. See why brokers dominate 70% of deals, private equity's role, and what to watch for in 2025.
Quantum stock dropped 22% in Q2 2026. Why did revenue miss by 10% ($185M) and what do falling margins mean for investors?
AI is changing P&C insurance jobs. Learn how insurers invest over $20B by 2028 and what skills employees need to adapt.